Overcoming Immune Resistance With Radiation Therapy in Prostate Cancer
An Erratum on
Overcoming immune resistance with radiation therapy in prostate cancer
by Mulvey A, Muggeo-Bertin E, Berthold DR and Herrera FG (2022) Front. Immunol. 13:859785. doi: 10.3389/fimmu.2022.859785
An omission to the funding section of the original article was made in error. The following sentence has been added: “Open access funding was provided by the University of Lausanne”.
The original version of this article has been updated.
Keywords: prostate cancer, radiation therapy, immunotherapy, immune checkpoint inhibitors, tumor micro-environment, cold tumor, abscopal effect
Citation: Frontiers Production Office (2023) Erratum: Overcoming immune resistance with radiation therapy in prostate cancer. Front. Immunol. 14:1185185. doi: 10.3389/fimmu.2023.1185185
Received: 13 March 2023; Accepted: 13 March 2023;
Published: 23 March 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org